Skip to main content

Table 2 Characteristics of PIMs at admission and at discharge among the 158 patients who survived until discharge

From: Intervention to improve the appropriate use of polypharmacy for older patients with hip fractures: an observational study

Category

Intervention

n = 31

Usual care

n = 127

 

At admission

At discharge

p-value

At admission

At discharge

p-value

Any PIMs,a n (%)

29 (93.5)

16 (51.6)

< 0.001

95 (74.8)

87 (68.5)

0.33

Benzodiazepines, n (%)

11 (35.5)

7 (22.6)

 

43 (33.9)

37 (29.1)

 

PPIs, n (%)

10 (32.3)

4 (12.9)

 

33 (26.0)

31 (24.4)

 

Hypnoticsb, n (%)

5 (16.1)

2 (6.5)

 

17 (13.4)

13 (10.2)

 

Antipsychotics, n (%)

4 (12.9)

2 (9.8)

 

12 (9.4)

9 (7.1)

 

Anticholinergics, n (%)

2 (6.5)

1 (3.2)

 

13 (10.2)

12 (9.4)

 

H2-receptor antagonistsc, n (%)

1 (3.2)

0 (0.0)

 

9 (7.1)

8 (6.3)

 

Anticonvulsants, n (%)

2 (6.5)

2 (6.5)

 

6 (4.7)

8 (6.3)

 

Opioids, n (%)

2 (6.5)

2 (6.5)

 

5 (3.9)

3 (2.4)

 

SSRIs, n (%)

1 (3.2)

1 (3.2)

 

4 (3.1)

4 (3.1)

 

Others, n (%)

5 (16.1)

1 (3.2)

 

12 (9.4)

11 (8.7)

 
  1. aPIMs were defined based on the 2015 American Geriatric Society Beers Criteria
  2. bThis category included non-benzodiazepine benzodiazepine receptor agonist hypnotics
  3. cThis category included only H2-receptor antagonist use for dementia